IL141691A0 - Polypeptides and polynucleotides from coagulase-negative staphylococci - Google Patents
Polypeptides and polynucleotides from coagulase-negative staphylococciInfo
- Publication number
- IL141691A0 IL141691A0 IL14169199A IL14169199A IL141691A0 IL 141691 A0 IL141691 A0 IL 141691A0 IL 14169199 A IL14169199 A IL 14169199A IL 14169199 A IL14169199 A IL 14169199A IL 141691 A0 IL141691 A0 IL 141691A0
- Authority
- IL
- Israel
- Prior art keywords
- coagulase
- polynucleotides
- polypeptides
- negative staphylococci
- staphylococci
- Prior art date
Links
- 241000295644 Staphylococcaceae Species 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 title 1
- 108091033319 polynucleotide Proteins 0.000 title 1
- 239000002157 polynucleotide Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9844398P | 1998-08-31 | 1998-08-31 | |
US11711999P | 1999-01-25 | 1999-01-25 | |
PCT/US1999/019728 WO2000012689A1 (en) | 1998-08-31 | 1999-08-31 | Polypeptides and polynucleotides from coagulase-negative staphylococci |
Publications (1)
Publication Number | Publication Date |
---|---|
IL141691A0 true IL141691A0 (en) | 2002-03-10 |
Family
ID=26794747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14169199A IL141691A0 (en) | 1998-08-31 | 1999-08-31 | Polypeptides and polynucleotides from coagulase-negative staphylococci |
Country Status (12)
Country | Link |
---|---|
US (4) | US6635473B1 (de) |
EP (3) | EP2311944A1 (de) |
JP (1) | JP4714342B2 (de) |
KR (1) | KR100871330B1 (de) |
CN (1) | CN1283798C (de) |
AU (1) | AU772547B2 (de) |
BR (1) | BR9913311A (de) |
CA (1) | CA2341018C (de) |
IL (1) | IL141691A0 (de) |
MX (1) | MXPA01002120A (de) |
NO (1) | NO20010980L (de) |
WO (1) | WO2000012689A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6692739B1 (en) * | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
GB0014907D0 (en) * | 2000-06-20 | 2000-08-09 | Univ Sheffield | Antigenic polypeptides |
US6835378B2 (en) * | 2001-05-11 | 2004-12-28 | The Texas A&M University System University | Method and compositions for inhibiting thrombin-induced coagulation |
EP2339344A1 (de) | 2001-06-15 | 2011-06-29 | Inhibitex, Inc. | Kreuzreaktive monoklonale und polyklonale Antikörper, die Oberflächenprotein aus koagulasenegativen Staphylococci und Staphylococcus Aureus erkennen |
JP2005536185A (ja) * | 2002-03-05 | 2005-12-02 | インヒビテックス インコーポレーテッド | コアグラーゼ陰性ブドウ球菌タンパク質を認識するモノクローナルおよびポリクローナル抗体 |
EP1565478B1 (de) * | 2002-11-12 | 2017-08-02 | The Brigham And Women's Hospital, Inc. | Polysaccharidimpfstoff gegenstaphylokokkeninfektionen |
NZ561879A (en) * | 2003-03-07 | 2009-05-31 | Wyeth Corp | Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
US20070026011A1 (en) * | 2003-05-29 | 2007-02-01 | Inhibitex, Inc. | Sdr proteins from staphylococcus capitis and their use in preventing and treating infections |
US7588773B2 (en) | 2004-08-24 | 2009-09-15 | St. Jude Children's Research Hospital | Methods and compositions for diagnosing and preventing a group B streptococcal infection |
EP1804833A2 (de) | 2004-09-22 | 2007-07-11 | GlaxoSmithKline Biologicals SA | Immunogene staphylokokken-zusammensetzungen |
AU2005333603A1 (en) * | 2004-10-21 | 2007-01-04 | Wyeth | Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens |
US20090214584A1 (en) * | 2005-05-31 | 2009-08-27 | Biostapro Ab | Characterization of novel lpxtg-containing proteins of staphylococcus epidermidis |
US8475798B2 (en) * | 2005-06-16 | 2013-07-02 | Inhibitex, Inc. | Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
EP1996231A4 (de) * | 2006-02-22 | 2010-09-15 | Texas A & M Univ Sys | Antikörper mit stark expressierter putativer antigenerkennung von ca-mrsa und verwendungsverfahren |
EP2476433A1 (de) | 2006-03-30 | 2012-07-18 | GlaxoSmithKline Biologicals S.A. | Immunogene Zusammensetzung |
WO2007136763A2 (en) * | 2006-05-19 | 2007-11-29 | Sanofi Pasteur, Inc. | Immunological composition |
WO2008088822A1 (en) * | 2007-01-16 | 2008-07-24 | The Trustees Of Columbia University In The City Of New York | Inhibiting staphylococcus epidermidis infections |
WO2008129428A2 (en) * | 2007-04-19 | 2008-10-30 | Molecular Detection Inc. | Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria |
US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
EP2666784B1 (de) | 2007-08-31 | 2017-04-05 | University Of Chicago | Verfahren und Zusammensetzungen zur Immunisierung gegen durch Staphylokokken vermittelte Lungenerkrankungen und -leiden |
CA2716706C (en) | 2008-03-03 | 2014-02-18 | Irm Llc | Compounds and compositions as tlr activity modulators |
EA023888B1 (ru) | 2008-03-14 | 2016-07-29 | Санофи Пастер Байолоджикс, Ллс | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов |
US8758765B2 (en) | 2008-07-29 | 2014-06-24 | The University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
CN102333540B (zh) | 2008-10-06 | 2015-04-22 | 芝加哥大学 | 与细菌eap、emp和/或adsa蛋白相关的组合物和方法 |
AU2010271116B2 (en) | 2009-04-03 | 2015-08-13 | University Of Chicago | Compositions and methods related to Protein A (SpA) variants |
EP2424999A1 (de) | 2009-04-30 | 2012-03-07 | Centre Hospitalier Universitaire Vaudois Lausanne (CHUV) | Modifizierte immunisierungsvektoren |
US9517263B2 (en) | 2009-06-10 | 2016-12-13 | Glaxosmithkline Biologicals Sa | Benzonaphthyridine-containing vaccines |
SI2445522T1 (sl) | 2009-06-22 | 2017-10-30 | Wyeth Llc | Imunogeni sestavki antigenov Staphylococcusa aureusa |
NZ616921A (en) | 2009-07-15 | 2015-06-26 | Genentech Inc | Gram-positive bacteria specific binding compounds |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
BR112012004806B8 (pt) | 2009-09-02 | 2022-10-04 | Novartis Ag | composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso |
WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
SG10201501980SA (en) | 2009-12-15 | 2015-05-28 | Novartis Ag | Homogeneous suspension of immunopotentiating compounds and uses thereof |
JP5848748B2 (ja) | 2010-03-23 | 2016-01-27 | アイアールエム・リミテッド・ライアビリティ・カンパニーIrm,Llc | 感染症、炎症、呼吸器疾患などの処置に使用するtlr2アゴニストとしての化合物(システインベースのリポペプチド)および組成物 |
US8808699B2 (en) | 2010-04-05 | 2014-08-19 | The University Of Chicago | Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response |
ES2655701T3 (es) | 2010-07-02 | 2018-02-21 | The University Of Chicago | Composiciones y métodos relacionados con variantes de la proteína A (SpA) |
US9192661B2 (en) | 2010-07-06 | 2015-11-24 | Novartis Ag | Delivery of self-replicating RNA using biodegradable polymer particles |
JP5793194B2 (ja) | 2010-09-09 | 2015-10-14 | ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago | 感染防御ブドウ球菌抗原が関与する方法および組成物 |
US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
CA2845259A1 (en) | 2011-08-15 | 2013-02-21 | The University Of Chicago | Compositions and methods related to antibodies to staphylococcal protein a |
ES2806945T3 (es) | 2012-04-26 | 2021-02-19 | Univ Chicago | Antígenos de coagulasa estafilocócica y métodos para su uso |
CA2910320A1 (en) | 2012-04-26 | 2013-10-31 | University Of Chicago | Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease |
CA2899787A1 (en) | 2013-02-01 | 2014-08-07 | Glaxosmithkline Biologicals Sa | Intradermal delivery of immunological compositions comprising toll-like receptor agonists |
WO2014140938A2 (en) | 2013-03-14 | 2014-09-18 | Centre Hospitalier Universitaire Vaudois | Immunological methods |
MX2020008417A (es) | 2018-02-12 | 2020-11-11 | Inimmune Corp | Ligandos de receptores de tipo toll. |
WO2021067785A1 (en) | 2019-10-02 | 2021-04-08 | Janssen Vaccines & Prevention B.V | Staphylococcus peptides and methods of use |
WO2022096590A1 (en) | 2020-11-04 | 2022-05-12 | Eligo Bioscience | Phage-derived particles for in situ delivery of dna payload into c. acnes population |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5055455A (en) * | 1988-09-28 | 1991-10-08 | Brigham And Women's Hospital | Capsular polysaccharide adhesin antigen, preparation, purification and use |
AU1570292A (en) | 1991-02-07 | 1992-09-07 | Board Of Trustees Of The University Of Illinois, The | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same |
KR19990082383A (ko) * | 1996-02-16 | 1999-11-25 | 스티븐슨 린다 에스. | 항균성 펩티드 및 이의 사용법 |
US6084084A (en) * | 1996-02-21 | 2000-07-04 | Nps Pharmaceuticals, Inc. | Human metabotropic glutamate receptor |
SE9602496D0 (sv) | 1996-06-20 | 1996-06-20 | Bengt Guss | Method and means for producing a fibrinogen binding protein and its use in biotechnology |
US6380370B1 (en) * | 1997-08-14 | 2002-04-30 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
CA2310217A1 (en) * | 1997-11-26 | 1999-06-03 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
ATE422368T1 (de) * | 1998-08-31 | 2009-02-15 | Inhibitex Inc | Multikomponenten impfstoffe gegen staphylococcus aureus |
-
1999
- 1999-08-31 WO PCT/US1999/019728 patent/WO2000012689A1/en active IP Right Grant
- 1999-08-31 AU AU55890/99A patent/AU772547B2/en not_active Ceased
- 1999-08-31 JP JP2000567676A patent/JP4714342B2/ja not_active Expired - Fee Related
- 1999-08-31 EP EP10182305A patent/EP2311944A1/de not_active Withdrawn
- 1999-08-31 EP EP99942534A patent/EP1117772B1/de not_active Expired - Lifetime
- 1999-08-31 CN CNB998104876A patent/CN1283798C/zh not_active Expired - Fee Related
- 1999-08-31 BR BR9913311-3A patent/BR9913311A/pt not_active Application Discontinuation
- 1999-08-31 CA CA2341018A patent/CA2341018C/en not_active Expired - Fee Related
- 1999-08-31 EP EP10181907A patent/EP2330192A1/de not_active Withdrawn
- 1999-08-31 KR KR1020017002671A patent/KR100871330B1/ko not_active IP Right Cessation
- 1999-08-31 US US09/386,962 patent/US6635473B1/en not_active Expired - Lifetime
- 1999-08-31 MX MXPA01002120A patent/MXPA01002120A/es active IP Right Grant
- 1999-08-31 IL IL14169199A patent/IL141691A0/xx not_active IP Right Cessation
-
2001
- 2001-02-27 NO NO20010980A patent/NO20010980L/no not_active Application Discontinuation
-
2003
- 2003-10-21 US US10/690,184 patent/US20040141997A1/en not_active Abandoned
- 2003-10-21 US US10/689,082 patent/US7473762B2/en not_active Expired - Lifetime
-
2006
- 2006-04-04 US US11/396,565 patent/US7709008B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR100871330B1 (ko) | 2008-12-01 |
JP2002528055A (ja) | 2002-09-03 |
US20040141997A1 (en) | 2004-07-22 |
CA2341018A1 (en) | 2000-03-09 |
CA2341018C (en) | 2012-07-31 |
NO20010980L (no) | 2001-04-30 |
US7709008B2 (en) | 2010-05-04 |
JP4714342B2 (ja) | 2011-06-29 |
KR20010085744A (ko) | 2001-09-07 |
EP1117772B1 (de) | 2012-10-24 |
EP1117772A1 (de) | 2001-07-25 |
AU5589099A (en) | 2000-03-21 |
MXPA01002120A (es) | 2003-03-27 |
CN1317043A (zh) | 2001-10-10 |
US20040142348A1 (en) | 2004-07-22 |
AU772547B2 (en) | 2004-04-29 |
EP2330192A1 (de) | 2011-06-08 |
CN1283798C (zh) | 2006-11-08 |
EP1117772A4 (de) | 2003-06-04 |
US6635473B1 (en) | 2003-10-21 |
WO2000012689A1 (en) | 2000-03-09 |
BR9913311A (pt) | 2001-10-16 |
NO20010980D0 (no) | 2001-02-27 |
US20060171964A1 (en) | 2006-08-03 |
US7473762B2 (en) | 2009-01-06 |
EP2311944A1 (de) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL141691A0 (en) | Polypeptides and polynucleotides from coagulase-negative staphylococci | |
PT1090128E (pt) | Polipéptidos dependentes da vitamina k modificados | |
IL139702A0 (en) | Hylbrid polypeptides with enhanced pharmacokinetic properties | |
EP1142992A4 (de) | Polypetide | |
HUP0102535A3 (en) | Cd19xcd3 specific polypeptides and uses thereof | |
AU5923398A (en) | Polynucleotides and polypeptides encoding receptors | |
IL179047A0 (en) | ??-amyloid peptide- binding proteins and polynucleotides encoding the same | |
EP1183344A4 (de) | Adam-polynukleotide und polypeptide | |
EP1049708A4 (de) | Meth1- und meth2- polynukleotide und polypeptide | |
EP1235846A4 (de) | Uteroglubinartige polynukleotide, polypeptide und antikörper | |
GB2318303B (en) | Barrel mixer | |
EP1218397A4 (de) | Attractin-ähnliche polynukleotide, polypeptide und antikörper | |
GB9929556D0 (en) | Portable telephone control system | |
GB9726539D0 (en) | Polypeptides, polynucleotides and uses thereof | |
HUP0103945A3 (en) | Moraxella catarrhalis basb034 polypeptides and uses thereof | |
EP1212415A4 (de) | Pgrp-l polynukleotide, polypeptide, und antikörper | |
GB9717416D0 (en) | Polypeptides,polynucleotides and uses thereof | |
GB9821362D0 (en) | Polynucleotides and polypeptides | |
GB9922243D0 (en) | Polynucleotides and polypeptides | |
AU2002227496A8 (en) | Polynucleotides and polypeptides | |
GB9817303D0 (en) | Polypeptides polynucleotides and uses thereof | |
EP1062228A4 (de) | Plasminogen-verwandte gen b-polypeptide | |
EP1009443A4 (de) | priA POLYPEPTIDE | |
GB2326437B (en) | Roof covering | |
ZA981962B (en) | A roof and components for the construction thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |